GET DAILY SIGNALSAmazon’s (AMZN, $1,742.15) venture into healthcare market is gaining momentum
E-commerce giant Amazon’s foray into the health care market is gaining ground. Amazon now allows customers who buy medicines from them to use their flexible savings account or health savings account, often referred to as HSA or FSA, to get discounts.
These programs allow customers with health insurance to reduce their out-of-pocket expenses by setting aside a portion of their pre-tax income to cover medical expenses like prescription medicines.
The move is intelligent to stay relevant in a market where rivals like Walmart (WMT) already offer pharmacy services and also have a storefront for HSA and FSA products.
In the summer of 2018, Amazon has also acquired an internet pharmacy company, PillPack, gesturing an interest to add prescription medicines in its portfolio. But PillPack, which primarily serves to older customers who take multiple medications, hasn’t been fully integrated with Amazon yet.
Amazon’s current interest in the prescription drugs market will not be without challenges owing to the complex web of intermediaries that sit between the drug manufacturer and the pharmacy. The company will now have to work closely with middlemen, known as pharmacy benefits managers, in order to take a customer’s insurance.
Amazon’s foray into the healthcare market was suspected due to the large segment of customers that pay put-of-pocket for their medical expenses. That’s about 6% of the U.S. population, which is a chunk of the $450 billion pharmacy market. Tapping this segment marks Amazon’s first move into the medicine market.
AMZN sees its Stochastic Oscillator ascending out of oversold territory
On November 03, 2026, the Stochastic Oscillator for AMZN moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 60 instances where the indicator left the oversold zone. In 46 of the 60 cases the stock moved higher in the following days. This puts the odds of a move higher at over 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +4.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMZN advanced for three days, in 224 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Aroon Indicator entered an Uptrend today. In 180 of 253 cases where AMZN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMZN as a result. In 43 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 55%.
The Moving Average Convergence Divergence Histogram (MACD) for AMZN turned negative on October 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In 31 of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at 54%.
AMZN moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AMZN crossed bearishly below the 50-day moving average on October 26, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMZN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
AMZN broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 50 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. AMZN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.902) is normal, around the industry mean (21.510). P/E Ratio (19.880) is within average values for comparable stocks, (9.793). Projected Growth (PEG Ratio) (1.460) is also within normal values, averaging (1.774). Dividend Yield (0.000) settles around the average of (0.032) among similar stocks. AMZN's P/S Ratio (3.447) is slightly higher than the industry average of (1.328).
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of on-line retail shopping services
Industry InternetRetail
Advertisement